Aquatic Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Other funds holding VRDN
KCM
Aquatic Capital Management's VRDN Position: Q3 2026 in Review
Aquatic Capital Management reduced its Viridian Therapeutics (VRDN) stake by 5.2% in Q3 2026, selling an estimated $88.3K and leaving 75,708 shares worth $1.56M. The position accounts for 0.05% of the portfolio, ranked #460.
Aquatic Capital Management first reported a position in VRDN in Q4 2025 and has held it in 4 quarters since. 235 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.
- Aquatic Capital Management held 75,708 shares of Viridian Therapeutics worth $1.56M as of Q3 2026.
- Aquatic Capital Management sold 4,137 Viridian Therapeutics shares in Q3 2026, an estimated $88.3K.
- Viridian Therapeutics made up 0.05% of Aquatic Capital Management's portfolio in Q3 2026, its #460 holding.
- Aquatic Capital Management first reported a position in Viridian Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 235 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.
Based on Aquatic Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.